MYB and pancreatic neoplasm: MiR-193b-3p has been previously characterised as a regulator of transcription factors such as MYB (Mets et al, 2015), downstream effector of MAPK (Ikeda et al, 2012) pathway and regulator of cell steaminess (Haetscher et al, 2015) in different tumour types including pancreatic cancers and leukaemia.